1. Home
  2. UFPT vs URGN Comparison

UFPT vs URGN Comparison

Compare UFPT & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

HOLD

Current Price

$337.68

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Logo UroGen Pharma Ltd.

URGN

UroGen Pharma Ltd.

HOLD

Current Price

$40.21

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFPT
URGN
Founded
1963
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
UFPT
URGN
Price
$337.68
$40.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$289.00
$29.29
AVG Volume (30 Days)
166.4K
717.0K
Earning Date
05-01-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
15.44
N/A
EPS
2.24
N/A
Revenue
$602,797,000.00
$1,128,000.00
Revenue This Year
$8.12
$129.09
Revenue Next Year
$5.72
$70.96
P/E Ratio
$119.43
N/A
Revenue Growth
19.50
N/A
52 Week Low
$173.86
$15.86
52 Week High
$279.49
$43.93

Technical Indicators

Market Signals
Indicator
UFPT
URGN
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
UFPT
URGN

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. The company manufactures its products by converting raw materials using laminating, molding, radio frequency, and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. The company's flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with Zusduri (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. The revenue source for the company comes from sales of the Company's approved products, Jelmyto and Zusduri, principally conducted in the United States.

Share on Social Networks: